share_log

香雪制药(300147.SZ):前三季度净亏损2.18亿元

Xiangxue Pharmaceutical (300147.SZ): a net loss of 0.218 billion yuan in the first three quarters.

Gelonghui Finance ·  Oct 25, 2024 22:04

GeLongHui October 25th | Xiangxue Pharmaceutical (300147.SZ) released the third quarter report for 2024, with the company achieving a revenue of 1.534 billion yuan in the first three quarters, a decrease of 11.26% year-on-year; net income attributable to shareholders of the listed company was -0.218 billion yuan; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was -0.205 billion yuan; basic earnings per share -0.3300 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment